Showing 1 - 10 of 602
We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...
Persistent link: https://www.econbiz.de/10014512103
The United States spends twice as much per person on pharmaceuticals as European countries, in large part because … reference countries. We estimate a structural model of demand and supply for pharmaceuticals in the US and reference countries …
Persistent link: https://www.econbiz.de/10013210081
prescription pharmaceuticals dispensed in hospitals, physician/clinic outpatient facilities, and nursing homes. Thus the CPI …-Rx overlooks the increasingly important specialty pharmaceuticals dispensed in hospitals, outpatient clinics, and physician offices … drug growth differs from that of traditional pharmaceuticals, the CPI-Rx could provide an inaccurate measure of overall …
Persistent link: https://www.econbiz.de/10013388804
Quality regulation attempts to ensure quality and foster competition by reducing vertical differentiation, but it may also have adverse effects on market structure. We study this trade-off in the context of pharmaceutical bioequivalence, which is the primary quality standard for generic drugs....
Persistent link: https://www.econbiz.de/10013361980
This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes driven by U.S. demographic trends, we find that a 1 percent increase in the potential market size for a drug category leads to a 4 to 6 percent...
Persistent link: https://www.econbiz.de/10012468658
rapid rise in direct-to-consumer advertising (DTCA), made feasible by the Food and Drug Administration's (FDA) clarification … and relaxation of the rules governing broadcast advertising in 1997 and 1999. This study investigates the separate effects …
Persistent link: https://www.econbiz.de/10012462683
nonmonotonic investment. The pharmaceutical data contain advertising, product proliferation, and pricing information for a sample … motivation are that incumbents in markets of intermediate size have lower levels of advertising and are more likely to reduce … advertising immediately prior to patent expiration …
Persistent link: https://www.econbiz.de/10012465585
In this paper we investigate how direct-to-consumer (DTC) advertising of pharmaceutical products in affected by … heavily regulated than cigarettes. Our empirical analysis uses data on advertising expenditures and data from an archive of … advertisements of prescription pharmaceuticals, substantially reducing the costs of a print advertisement. Our results suggest that …
Persistent link: https://www.econbiz.de/10012466670
empirical study of the impact of pharmaceutical industry advertising on smoking cessation decisions. We link survey data on … consumers that the advertisers observe, we can control for the potential endogeneity of advertising due to firms' targeting … decisions. We find that when smokers are exposed to more advertising, they are more likely to attempt to quit and are more …
Persistent link: https://www.econbiz.de/10012466733
We examine the effect of direct-to-consumer advertising (DTCA) of drug treatment on an important health habit, physical …
Persistent link: https://www.econbiz.de/10012466901